InterCure Ltd.
INCR
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.āāā ā
Healthcare
Drug ManufacturersāSpecialty & Generic
6 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$1.36
Price-6.21%
-$0.09
1Y
Price
Market Cap
$74.367m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+11.0%
EBITDA Margin-1.3%
Net Profit Margin+6.9%
Free Cash Flow MarginRevenue
$243.123m
+1.8%
1y CAGR-13.2%
3y CAGR+9.4%
5y CAGREarnings
-$70.932m
-4.6%
1y CAGR-84.1%
3y CAGR+150.8%
5y CAGREPS
-$1.61
-13.4%
1y CAGR-85.0%
3y CAGR+136.2%
5y CAGRBook Value
$432.244m
$751.763m
Assets$319.519m
Liabilities$179.341m
DebtDebt to Assets
23.9%
-2.3x
Debt to EBITDAFree Cash Flow
$8.953m
+112.6%
1y CAGR-64.2%
3y CAGR-1.4%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in ILS.No items found.
Press Releases
Statements and updates from the company